MARKET

CERT

CERT

Certara, Inc.
NASDAQ
8.74
+0.16
+1.86%
After Hours: 8.77 +0.03 +0.34% 17:15 12/15 EST
OPEN
8.66
PREV CLOSE
8.58
HIGH
8.83
LOW
8.42
VOLUME
3.92M
TURNOVER
--
52 WEEK HIGH
15.69
52 WEEK LOW
8.03
MARKET CAP
1.39B
P/E (TTM)
129.29
1D
5D
1M
3M
1Y
5Y
1D
Certara Price Target Cut to $13.00/Share From $14.00 by Barclays
Dow Jones · 1h ago
Certara Is Maintained at Overweight by Barclays
Dow Jones · 1h ago
Barclays Maintains Overweight on Certara, Lowers Price Target to $13
Benzinga · 1h ago
CERTARA <CERT.O>: BARCLAYS CUTS TARGET PRICE TO $13 FROM $14
Reuters · 11h ago
Certara price target lowered to $13 from $14 at Barclays
TipRanks · 11h ago
Weekly Report: what happened at CERT last week (1208-1212)?
Weekly Report · 12h ago
U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp
Reuters · 14h ago
Analysts Are Bullish on Top Healthcare Stocks: Certara (CERT), Sera Prognostics (SERA)
TipRanks · 1d ago
More
About CERT
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.

Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERT stock methods without spending real money on the virtual paper trading platform.